Skip to content
Screener

Gyre Therapeutics, Inc. GYRE Balance Sheet Statement

Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
$41.64M+3.1%$43.29M+18.6%$37.5M+149%$49.19M+316%$40.4M+155%
$15.77M-19.7%$14.06M-21.3%$12.31M-17.1%$15.36M+3.3%$19.65M+113%
$32.66M+26.2%$27.76M+12.7%$22.76M+13.0%$31.08M+58.7%$25.88M+32.8%
$12.22M+38.0%$11.43M+29.0%$11.35M+44.1%$10.17M+60.5%$8.85M+38.8%
$123.4M+25.2%$122.07M+33.7%$91.73M+34.0%$149.36M+131%$98.58M+79.9%
$27.01M+14.4%$27.28M+16.6%$23.57M+0.2%$27.55M+15.4%$23.61M-3.4%
$4.4M-9.1%$4.53M-8.8%$4.63M-9.0%$4.73M+1,632%$4.85M+2,534%
$201.25M+26.3%$199.26M+30.5%$162.02M+24.8%$219.76M+75.2%$159.38M+27.3%
$2.64M+374%$1.24M+1,641%$265K+117%$1.34M+1,136%$556K+83.5%
$1.56M+2,581%$829K—$840K+2,900%$14K-77.0%$58K-68.6%
$28.59M+79.6%$28.66M+69.4%$19.79M+4.2%$23.78M+21.9%$15.91M+8.1%
$35.18M+60.1%$34.34M+48.0%$25.03M-1.8%$31.4M+16.3%$21.97M-17.9%
$107K+17.6%$106K+16.5%$91K+4.6%$91K+5.8%$91K+7.1%
-$142.02M-113%-$137.96M-96.2%-$77.67M-9.8%-$112.6M-53.3%-$66.7M+9.1%
$107.95M+5.9%$107.93M+17.3%$101.31M+48.7%$62.5M-1.3%$101.92M+61.3%
$201.25M+26.3%$199.26M+30.5%$162.02M+24.8%$219.76M+75.2%$159.38M+27.3%

FAQ

What are Gyre Therapeutics, Inc.'s total assets?
Gyre Therapeutics, Inc. (GYRE) holds $201.3M in total assets, up 26.3% year over year.
How much debt does Gyre Therapeutics, Inc. have?
Gyre Therapeutics, Inc. carries $3.0M in total debt against $108.0M of shareholders' equity, a debt-to-equity ratio of 0.03.
How much cash does Gyre Therapeutics, Inc. have?
Gyre Therapeutics, Inc. holds $41.6M in cash and equivalents.
Can Gyre Therapeutics, Inc. cover its short-term obligations?
Its current ratio is 4.32 — current assets exceed current liabilities.
Where does Gyre Therapeutics, Inc.'s balance sheet data come from?
Every line is extracted from Gyre Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.